Updates to safety labelling for benzodiazepines and benzodiazepine-like drugs

Benzodiazepines and benzodiazepine-like prescription drugs—commonly used to treat sleep and anxiety disorders, certain seizure disorders, and to help relax muscles or relieve muscle pain—can lead to problematic use and substance use disorder. To help mitigate these risks, Health Canada is asking manufacturers to update their safety warnings to include more prominent and consistent messaging for patients and healthcare professionals.